# A Study With NLY01 in Subjects With Type 2 Diabetes

> **NCT04159766** · PHASE2 · COMPLETED · sponsor: **Neuraly, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Type2 Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** NLY01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04159766
- **Lead sponsor:** Neuraly, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-16
- **Primary completion:** 2020-12-04
- **Final completion:** 2020-12-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04159766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04159766, "A Study With NLY01 in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04159766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*